Furthermore, the stability and solubility of a passenger protein can be improved by fusing it to MBP (12)

Furthermore, the stability and solubility of a passenger protein can be improved by fusing it to MBP (12). after the immunization. These results suggest that 25k-hagA-MBP administered nasally would be an effective and safe mucosal vaccine againstP. gingivalisinfection and may be an important tool for the prevention of chronic periodontitis in humans. Chronic periodontitis is usually a common oral inflammatory disease that causes the breakdown of periodontal tissues, including resorption of alveolar bone and tooth loss (7). Furthermore, recent studies have exhibited that periodontitis is much more than a localized oral infection: it may cause adverse changes in systemic physiology, such as cardiovascular disease, diabetes, and osteoporosis (2,9,15,23,28,38,39,45). Hence, prevention of periodontitis is usually important for both oral and systemic health. Subgingival Gram-negative Tianeptine sodium bacteria are associated with the onset and progression of chronic periodontitis; populations of a few opportunistic pathogens, includingPorphyromonas gingivalis, are increased during development from a healthy site to a diseased site (7,22). Molecules such as fimbriae, aggregation factors, lipopolysaccharides, and numerous proteolytic enzymes responsible for colonization have been identified as virulence factors (22,37). Hemagglutinin, which is known to be located on the cell surface and in vesicles ofP. gingivalis, has been proposed to mediate bacterial attachment to, and penetration of, host cells and may also agglutinate and lyse erythrocytes in order to take up heme, an absolute requirement for the growth of the bacterium (6,8,41). Multiple hemagglutinin genes have been cloned fromP. gingivalisby functional screening (35,42,44,49). Among these, hemagglutinin A (HagA) has been thought to contain the functional domain name of hemagglutinin and to be a potentially useful immunogen that elicits a protective immune response against subsequent colonization byP. gingivalis(30). ThehagAgene is usually 7,887 bp long and encodes a protein of 2,628 amino acids, with a molecular mass of 283.3 kDa (17). This gene has four large, contiguous direct repeats, and the repeat unit is believed to contain the Tianeptine sodium hemagglutinin domain name (17). Previous studies have exhibited the molecular cloning of a 200-kDa antigenic protein (200-k AP) fromP. gingivalisand have shown that 200-k AP is usually identical to HagA (10,19). Furthermore, the DNA sequence of a subclone encoding the 25-kDa antigenic region of 200-k AP (25k-hagA) is usually identical to that of the first repeat ofhagA(10). These studies suggest that 25k-hagA may be a useful vaccine antigen (Ag) for the prevention of periodontitis caused byP. gingivalisinfection. Maltose-binding protein (MBP) is Tianeptine sodium usually a high-affinity maltose/maltodextrin-binding protein responsible for Tianeptine sodium the capture and transport of maltodextrins from your periplasmic space in Gram-negative bacteria (4). MBP is used as a fusion partner for recombinant protein expression to improve TXNIP the yield and to facilitate the purification of fusion proteins (5,47). Furthermore, the stability and solubility of a passenger protein can be improved by fusing it to MBP (12). Recently, MBP was used as a chaperone component in various vaccines and was shown to enhance antigen-specific immune responses (32,46,48,51,52). In this regard, a previousin vitrostudy has shown that MBP induces dendritic cell (DC) activation and increases I phosphorylation in treated cells. Furthermore, phosphorylation of I is largely abrogated by the addition of antibodies against toll-like receptor 4 (TLR4) (11). These findings suggest that MBP stimulates DCs via TLR4, and this may account for the adjuvanticity of MBP. In the present study, we assessed the Tianeptine sodium potential of a fusion protein consisting of the 25-kDa antigenic region ofP. gingivalisHagA and MBP (25k-hagA-MBP) as a nasal vaccine for the prevention of oral contamination withP. gingivalis. The results suggest that nasal 25k-hagA-MBP is usually a practical, effective, and safe vaccine candidate for the induction of protective immunity against alveolar bone loss caused byP. gingivalisinfection. == MATERIALS.